Does RISANKIZUMAB-RZAA Cause Neurodermatitis? 5 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Neurodermatitis have been filed in association with RISANKIZUMAB-RZAA. This represents 0.0% of all adverse event reports for RISANKIZUMAB-RZAA.
5
Reports of Neurodermatitis with RISANKIZUMAB-RZAA
0.0%
of all RISANKIZUMAB-RZAA reports
0
Deaths
4
Hospitalizations
How Dangerous Is Neurodermatitis From RISANKIZUMAB-RZAA?
Of the 5 reports, 4 (80.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Neurodermatitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Neurodermatitis?
DUPILUMAB (1,577)
NEMOLIZUMAB-ILTO (109)
ADALIMUMAB (42)
SECUKINUMAB (29)
ETANERCEPT (24)
ATORVASTATIN (23)
OCRELIZUMAB (21)
TACROLIMUS (21)
ARIPIPRAZOLE (18)
METFORMIN (18)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Neurodermatitis Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA